Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors：A Prospective Exploratory Study

Name: Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors：A Prospective Exploratory Study
License: Public Domain

Ningbo Medical Center Lihuili Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

pancreatic-cancer

pancreatic cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 184873
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.